Enzymes for transforming ergopeptines and method therefor

Abstract

Enzymes for transforming, in particular hydrolytically cleaving, ergopeptines, which ergopeptines are /-hydrolases hydrolytically cleaving ergopeptines in the cyclol ring, for the transformation of ergopeptines, and method for producing ergopeptine-metabolizing enzymes.

Claims

1. A method for hydrolysis of ergopeptine comprising contacting /-hydrolase with ergopeptine wherein the C3-N bond of the oxazolidine-4-one ring is cleaved to a primary metabolite, wherein the /-hydrolase has at least 96% sequence identity with SEQ ID NO: 1.

2. The method according to claim 1, wherein ergine is formed in a subsequent reaction of the primary metabolites.

Description

BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS(S)

(1) In the following, the invention will be explained in more detail by way of exemplary embodiments and Figures. Therein,

(2) FIG. 1 illustrates the kinetics of the reaction of ergotamine to ergine with the enzyme having sequence ID No. 1;

(3) FIG. 2 illustrates the reaction of the ergopeptines ergocomine, ergocryptine, ergosine, ergovaline and ergotamine by the enzyme of sequence ID No. 1 with the exemplary negative controls for ergocryptine and ergosine,

(4) wherein FIG. 2a illustrates the reaction of ergocomine by the enzyme of sequence ID No. 1,

(5) FIG. 2b illustrates the reaction of ergocristine by the enzyme of sequence ID No. 1,

(6) FIG. 2c illustrates the reaction of ergocryptine by the enzyme of sequence ID No. 1,

(7) FIG. 2d illustrates the reaction of ergosine by the enzyme of sequence ID No. 1,

(8) FIG. 2e illustrates the reaction of ergovaline by the enzyme of sequence ID No. 1,

(9) FIG. 2e illustrates the reaction of ergotamine by the enzyme of sequence ID No. 1,

(10) FIG. 2f illustrates the negative control ergocryptine and

(11) FIG. 2g illustrates the negative control ergosine;

(12) FIG. 3 is an illustration of the P. pastoris expression vector pGAPZ alphaC with the gene sequence ID No. 2; and

(13) FIG. 4 is an illustration of the B. subtilis expression vector pET43 with the gene sequence ID No. 2.

DETAILED DESCRIPTION OF THE INVENTION

Example 1

Determination of the Catalytic Activity of the Enzyme with the Sequence ID No. 1

(14) The gene with the sequence ID No. 2, which codes for an /-hydrolase comprising a catalytic triad of S94-D234-H270, was cloned into the expression vector pET28a(+) by applying standard methods, transformed and expressed in E. coli. Following the expression in E. coli BL21(DE3), the his-tagged enzyme was purified by affinity chromatography. The enzyme concentration was determined using a Pierce BSA Protein Assay Kit, and the enzyme was used in activity assays. The assays were carried out in 50 mM sodium phosphate buffer (pH 7.0) at 25 C.

(15) In the context of the detoxification assays, enzyme concentrations of 0.079 g/ml and ergotamine concentrations of 5 mg/kg were used.

(16) A further assay for reacting the six ergopeptines, namely ergotamine, ergovaline, ergocomine, ergocristine, ergocryptine or ergosine, and their respective isomeric forms, namely ergotaminine, ergovalinine, ergocominine, ergocristinine, ergocryptinine and ergosinine, used 1.58 g/ml of the enzyme with sequence ID No. 1 and 10 mg/kg ergotamine, or the equimolar (summation) concentrations of the remaining ergopeptines or their epimers. The results are indicated in FIG. 2.

(17) The samples were analyzed using HPLC-FLD or HPLC-MS/MS, each by analytically determining the respective concentration of the sum of the respective epimers. Simultaneously with the determination of the ergopeptine concentration during the enzymatic reaction, the formation of the ergo hydroxy acid (metabolite 1) and of the ergoproline cyclodipeptide (metabolite 2) was observed. During the continued reaction course, the conversion of metabolite 1 to ergine was detected.

(18) FIG. 1 exemplarily shows the kinetics of the reaction of ergotamine with sequence ID No. 1. During said reaction, slight amounts of an instable intermediate product were detected, and the end production of the reaction was ergine. From FIG. 1, it is apparent that an almost complete degradation of ergotamine to ergine by sequence ID No. 1 occurred within 4 hours. The reaction courses of all other ergopeptines, namely ergovaline, ergocomine, ergocristine, ergocryptine or ergosine, as well as their respective isomeric forms, namely ergovalinine, ergocominine, ergocristinine, ergocryptinine and ergosinine, are comparable.

Example 2

(19) Identification of the N-terminus of the enzyme with the sequence ID No. 1 To identify the N-terminus of the enzyme with sequence ID No. 1, the genes having sequences ID No. 2 and ID No. 6 were cloned into PET28a(+) and transformed into E. coli using standard methods.

(20) Following the expression, the bacteria cells were taken up in 50 mM sodium phosphate buffer and lyzed using a French press (20,000 psi). The lysates were used in dilutions of 1:10, 1:100 and 1:1000 in degradation batches of 5 mg/kg ergotamine. The batches were incubated at 25 C., and the samples were analyzed using HPLC-FLD.

(21) The results of the degradation test indicated that both of the enzymes were able to transform ergotamine. However, the enzyme with the shorter nucleotide sequence displayed a significantly higher activity, this variant thus having been able to completely transform ergotamine even in the 1:1000 dilution, the longer variant displaying only little activity already in the 1:100 dilution.

Example 3

Determination of the Temperature Range of the Activity, and the Temperature Stability, of the Enzyme with the Sequence ID No. 1

(22) In order to determine the optimum temperature for the activity of the enzyme with the sequence ID No. 1, 0.1 g/ml enzyme was incubated with 5 mg/kg ergotamine in Teorell-Stenhagen universal buffer (pH 9.0) at varying temperatures ranging from 10 C. to 50 C. The enzyme displayed activity in a range of 10 C. to 35 C. with an optimum at 35 C., based on the starting speed.

(23) In order to determine the temperature stability, the enzyme was incubated for 1 h at varying temperatures ranging from 10 C. to 60 C. After this, the enzyme solutions were incubated at concentrations of 0.1 g/ml in Teorell-Stenhagen universal buffer (pH 7.0) with 0.1 mg/ml BSA and 5 mg/kg ergotamine at 25 C. The results indicate that the enzyme is stable up to a temperature of 30 C., still displaying some activity after incubation at 40 C., yet showing a decrease of activity between 35 and 40 C. To sum up, it has turned out that the enzyme with the sequence ID No. 1 substantially shows the temperature optimum at the temperature conditions found in the gastrointestinal tract.

Example 4

Determination of the pH Optimum of the Activity, and the pH Stability, of the Enzyme with the Sequence ID No. 1

(24) In order to determine the optimum pH range for the activity of ErgA, 0.1 g/ml enzyme was incubated with 5 mg/kg ergotamine at varying pH values using Teorell-Stenhagen universal buffer at 25 C. Said buffer was chosen, since the combination of citrate, phosphate and borate allows for the adjustment of the same buffer capacity in a range of pH 2 to pH 12 by hydrochloric acid. The enzyme displayed activity in a range of pH 6 to pH 11 with a small activity plateau at pH 8 to pH 9.

(25) In order to determine the pH stability, the enzyme was incubated for 1 h at 25 C. at varying pH values ranging from pH 2 to pH 12. After this, the enzyme solutions in concentrations of 0.1 g/ml were incubated with 0.1 mg/ml BSA and 5 mg/kg ergotamine in Teorell-Stenhagen universal buffer (pH 7.0) at 25 C. Also in this case an activity plateau appeared, this time in the range of pH 6 to pH 9, with a strongly decreasing activity outside this range. The activity in this range ensures the technological application of the enzyme with the sequence ID No. 1 as a feed additive.

Example 5

Expression of the Enzyme with the Sequence ID No. 1 in Picha pastoris

(26) The gene with the sequence ID No. 2 was cloned into pGAPZ alpha C, transformed into P. pastoris, and expressed using standard methods. The expression vector pGAPZ alphaC with the gene having the sequence ID No. 2 is illustrated in FIG. 3. A degradation assay was carried out in 50 mM sodium phosphate buffer (pH 7.0) with 5 mg/kg ergotamine at 25 C. From the culture supernatant, a 1:100 dilution was used. The samples were analyzed by HPLC-FLD. Based on the results from SDS-PAGE and degradation assays, an expression of the enzyme with the sequence ID No. 1 in the culture supernatant could be confirmed.

Example 6

Expression of the Enzyme with the Sequence ID No. 1 in Bacillus subtilis

(27) The gene with the sequence ID No. 2 was cloned into pHT43, transformed into B. subtilis, and expressed using standard methods. The expression vector pHT43 with the gene having the sequence ID No. 2 is illustrated in FIG. 4. A degradation assay was carried out in 50 mM sodium phosphate buffer (pH 7.0) with 5 mg/kg ergotamine at 25 C. From the culture supernatant, a 1:10 dilution was used. The samples were analyzed by HPLC-FLD. Based on the results from SDS-PAGE and degradation assays, an expression of ErgA in the culture supernatant could be confirmed.

Example 7

Degradation Assay in the Rumen Model

(28) The activity of the ergot alkaloid-degrading enzyme of the enzyme with the sequence ID No. 1 was tested in an in-vitro rumen model. To this end, fresh rumen juice was diluted 1:1 using a solution consisting of synthetic rumen juice, hay and a cereal mixture of wheat, maize and soy. To demonstrate the reaction of the ergopeptines, a batch was supplemented with the enzyme of sequence ID No. 1 (1 g/ml) and 5 mg/kg ergotamine. Fermentation tubes were used over septums, and the batches were incubated in water bath at 39 C. Analytics by means of HPLC/ESI-MS/MS showed that ergotamine had been completely converted into ergine and lysergic acid in the rumen model.

LITERATURE

(29) MARTINKOVA, L., KREN, V., CVAK, L., OVESNA, M. & PREPECHALOVA, I. 2000. Hydrolysis of lysergamide to lysergic acid by Rhodococcus equi A4. J. Biotechnol., 84, 63-66. KOURIST, R., JOCHENS, H., BARTSCH, S., KUIPERS, R., PADHI, S. K., GALL, M., BTTCHER, D., JOOSTEN, H.-J. & BORNSCHEUER, U. T. 2010, The / Hydrolase Fold 3DM Database (ABHDB) as a Tool for Protein Engineering. Chem Bio Chem, 11, 1635-1643. OLLIS, D. L., CHEAH, E., CYGLER, M., DIJKSTRA, B., FROLOW, F., FRANKEN, S. M., HAREL, M., REMINGTON, S. J., SILMAN, I. & SCHRAG, J. 1992. The alpha/beta hydrolase fold. Protein Eng., 5, 197-211. SCHARDL C. L., PANACCIONE D. G. & TUDZYNSKI P. 2006. Ergot AlkaloidsBiology and Molecular Biology. The Alkaloids, 63, 45-86. YAMADA Y., MATSUDA M., MAEDA K. & MIKATA K. 1995. The Phylogenetic Relationship of Methanol-assimilating Yeasts Based on the Partial Sequence of 18S and 26S Ribosomal RNAs: The Proposal of Komagataella Gen. Nov. (Saccharomycetaceae). Biosci. Biotech. Biochem., 59(3), 439-444.